Shield Therapeutics PLC (STX)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
5.70p
Buy
5.80p
-0.10p (-1.71%)
Prices updated at 03 Jun 2026, 17:07 BST
| Prices minimum 15 mins delay
Prices in GBX
Shield Therapeutics PLC is a commercial-stage specialty pharmaceutical company that delivers ACCRUFeR/FeRACCRU (ferric maltol), a differentiated pharmaceutical product, to address the unmet need for patients suffering from iron deficiency, with or wit ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
29 May 202630 Apr 202609 Apr 202601 Apr 202631 Mar 202631 Mar 202603 Mar 202627 Feb 202609 Feb 202630 Jan 2026
Key dates
| Forecast date | |
|---|---|
| Final results | Apr 2027 |
| Annual report | Apr 2027 |
| Annual general meeting | Jun 2026 |
| Half yearly results | - |
| Previous date | |
|---|---|
| Annual report | Apr 2026 |
| Final results | Apr 2026 |
| Half yearly results | Aug 2025 |
| Annual general meeting | May 2025 |
Company reports
31 Dec 2025
Annual Report 30 Jun 2025
Quarterly Report 